Kudo Biotechnology的动态

Financing #drugdevelopment programs can be tricky. ?? Typically, the stakes are high, the expertise gap is wide, and study timelines are long. So today, we hosted Lundbeckfonden / Lundbeck Foundation to discuss their Frontier Grant program, which provides important financial and interactive support commercial and translational development for therapeutic research. Awardees get mentoring + professional development to boot! Events like this ensure Syddansk Universitet - University of Southern Denmark researchers talk to financers EARLY and learn what #venturecapital investors will want to see/know down the commercial development road. Thank you to Paul E.G. Kristjansen, Liane Dupont, and Kevin Dolowy Dalgaard for coming to see us. Thank you to Jakob M?ller-Jensen, Uffe Holmskov + all the motivated researchers from Syddansk Universitet - University of Southern Denmark who joined the discussion! .... + Well done Lene Aarenstrup Nielsen + Liv Thomsen for pulling off another productive partner event! #grants #venturecapital #lifescience #biotech #danskbiotek #therapeutics SDU RIO

???? We’re pleased to partner NSG BioLabs on its fourth facility in the Geneo life sciences and innovation cluster at #SingaporeSciencePark. Combining CapitaLand’s real estate expertise with NSG BioLabs’ deep experience and networks in the biotech ecosystem, this collaboration will create Southeast Asia’s largest co-working laboratory space at approximately 35,000 square feet (sq ft) and will bring NSG BioLab’s total size to more than 70,000 sq ft. This partnership marks an exciting development for Geneo as we introduce #biotech co-working lab space to support the growth of the #lifesciences and deep tech companies in Singapore. From developing pioneering products to fostering industry engagements, Geneo is set to become a key driver of #innovation and collaboration in Singapore's thriving biotech ecosystem. Jointly developed by #CapitaLandDevelopment and CapitaLand Ascendas REIT (#CLAR), Geneo comprises three properties with five state-of-the-art buildings that will offer about 1.94 million sq ft of gross floor area with work-live-play elements when fully completed in 2025. Peet Mun Chew Daphne Teo

If you want to discover Exiting News from InnoSyn, talk to us at the NLS days or via different channels. Those interested in AI supported in-silico screening of compound libraries, enzymes and receptors should know about SynSilico, our Joint Venture with GenzAI which provides AI solutions to the Life Science community to speed-up screening and process optimization tasks. #innosyn #genzai #screening #Processoptimization #NLSdays #synsilico

There's been a lot going on at Allumiqs, and we're not stopping anytime soon! If you'll be at any of the events on our calendar, connect with my colleagues to find out what we've been up to - and what's on the horizon! And tell us what you're up to; we love finding new ways to collaborate. #multiomics #drugdevelopment #proteomics #metabolomics

A lab without Labguru? It wasn't an option for Dr. Alon Silberman, MitoCareX Bio Co-Founder and Chief Scientific Officer. MitoCareX Bio is a successful early-stage drug discovery startup. They've been using Labguru since day 1. With us, they have: ?? Saved 3+ hours every week ?? Saved $300/month thanks to effective inventory management ?? Simplified experiment planning & improved consistency of results ??? Made lab data centralized, searchable, and traceable We interviewed Dr. Alon Silberman, MitoCareX Bio Co-Founder and Chief Scientific Officer, to discover why he couldn't imagine lab life without Labguru. This is what he said ?? ??Full Case study: https://bit.ly/4dEDQfn

??We’re immensely proud of the collaborative nature of our Campus community that facilitates opportunities to drive innovation. It has seen PlaqueTec Ltd. a pioneering company dedicated to advancing the understanding of coronary artery disease (CAD), partner with international leader in drug discovery and development services RxCelerate. The collaborative project aimed to assess small molecules identified from an initial cheminformatics drug screen in a bespoke cell-based assay developed by RxCelerate on one of PlaqueTec’s targets discovered in pilot studies. It provided valuable insights into the biology of CAD and both companies are keen for further collaboration as new targets are identified and validated through ongoing research. Our unique Campus ecosystem has allowed PlaqueTec to not only progress its core research but also forge partnerships that are critical to its mission. Take a look at the case study on p9 of our Babraham Research Campus Impact Report summary to find out more – https://ow.ly/vOyS50UpFcq #Collaboration #LifeSciences #BabrahamImpact #ResearchCampus

Kind reminder for the coming webinar, presented by Dr. John Dulos, a renowned translational science expert and co-inventor of anti-PD1 pembrolizumab (Keytruda). Don't miss his talk 'Turning Setbacks into Success: Translational Science in Action'.

?? We're continuing our 20th anniversary celebrations with the second video in our series honouring our life sciences ecosystem and how our community has grown. ?? In today's film, Luc Henry, Founder and CEO of?Limula,?summarises how a life sciences company affects and is affected by its environment: 'Now that I'm building a company, the more we advance, the more I realise that it's critical to foster the ecosystem – the talent and the people. The more people have been through the start-up journey, whether they're still in it as innovators or whether they're successful entrepreneurs, the more value it creates in the region.' ?? Thanks to Luc,?Henri Kornmann (Head of Ferring Pharmaceuticals's Biologics Innovation Centre), Siew-Veena Sahi (Co-Founder and CEO of Testmate Health) and Pierre-Jean Wipff (Innovation and Partnerships Director here at Biop?le Lausanne) for their contributions to today's video.

Inspired by fictional X-Men ????♂? ????♀? A few yrs ago Lux started + funded a cutting-edge biotech Variant Bio (now funded with over $100million) With a focus on real-life genetic outliers x AI x remote populations ??+?? = ?? Today’s front page of NYT––genius founder CTO Stephane Castel + CEO Andrew Farnum + CSO David Moller + their new $50M deal with Novo Nordisk https://lnkd.in/eBQKZXS8

When people think of ??????????????, they often envision ????????????????, ??????????????, ?????? ?????????????????? ???????—not necessarily ????????????????????, ????????????????????????, ?????? ?????????????? ???????????????????? ??????????????????. ?????? ???????? ???????? ???????? ????????????! We realized this yesterday at the BioFlorida, Inc. event hosted at NeoGenomics Laboratories’ headquarters. If you haven’t heard of ????????????????????, we encourage you to follow them and see the remarkable work they are doing to transform Florida into a competitive biotech hub! It was inspiring to explore how Clara can contribute to pushing the boundaries of life sciences in Florida through our ???? ????????????????????????, ???????? ??????????????????, ?????? ???? ????????????????, putting our extensive experience and expertise at the disposal of the industry. We also had the privilege of touring ??????????????????????’ state-of-the-art labs, where ???????? ?????????????? ???????? ???????? ?? ?????????????? ???????????????? ?????????? ?????? ???????? ??. Witnessing their cutting-edge operations firsthand was incredible. Excited about the potential collaborations and innovations ahead as we are in the process of becoming BioFlorida members! #Florida #Biotech #LifeSciences #BioFlorida #NeoGenomics #Innovation #AI #DataAnalytics #ITAugmentation #Clara #Oncology #BiotechHub #Collaboration #Laboratories #CuttingEdgeTechnology #Healthcare #BiotechInnovation